Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL

Abstract

Growth/differentiation factor 15 (GDF15), also known as MIC-1, is a distant member of the transforming growth factor-β (TGF-β) superfamily and has been implicated in various biological functions, including cancer cachexia, renal and heart failure, atherosclerosis and metabolism1. A connection between GDF15 and body-weight regulation was initially suggested on the basis of an observation that increasing GDF15 levels in serum correlated with weight loss in individuals with advanced prostate cancer2. In animal models, overexpression of GDF15 leads to a lean phenotype, hypophagia and other improvements in metabolic parameters3, suggesting that recombinant GDF15 protein could potentially be used in the treatment of obesity and type 2 diabetes. However, the signaling and mechanism of action of GDF15 are poorly understood owing to the absence of a clearly identified cognate receptor. Here we report that GDNF-family receptor α-like (GFRAL), an orphan member of the GFR-α family, is a high-affinity receptor for GDF15. GFRAL binds to GDF15 in vitro and is required for the metabolic actions of GDF15 with respect to body weight and food intake in vivo in mice. Gfral−/− mice were refractory to the effects of recombinant human GDF15 on body-weight, food-intake and glucose parameters. Blocking the interaction between GDF15 and GFRAL with a monoclonal antibody prevented the metabolic effects of GDF15 in rats. Gfral mRNA is highly expressed in the area postrema of mouse, rat and monkey, in accordance with previous reports implicating this region of the brain in the metabolic actions of GDF15 (refs. 4,5,6). Together, our data demonstrate that GFRAL is a receptor for GDF15 that mediates the metabolic effects of GDF15.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: GFRAL interacts with GDF15.
Figure 2: GDF15 does not suppress body weight and food intake in Gfral−/− mice.
Figure 3: GFRAL antibody blocks GDF15-induced body-weight and food-intake suppression in Sprague–Dawley rats.
Figure 4: Gfral expression in brain tissue from different species and continuous food-intake monitoring.

Similar content being viewed by others

Accession codes

Accessions

NCBI Reference Sequence

References

  1. Adela, R. & Banerjee, S.K. GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. J. Diabetes Res. 2015, 490842 (2015).

    Article  Google Scholar 

  2. Brown, D.A. et al. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis Rheum. 56, 753–764 (2007).

    Article  CAS  Google Scholar 

  3. Chrysovergis, K. et al. NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism. Int. J. Obes. (Lond) 38, 1555–1564 (2014).

    Article  CAS  Google Scholar 

  4. Borner, T. et al. Anorexia–cachexia syndrome in hepatoma tumour–bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC-1/GDF15. J. Cachexia Sarcopenia Muscle 8, 417–427 (2016).

    Article  Google Scholar 

  5. Johnen, H. et al. Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1. Nat. Med. 13, 1333–1340 (2007).

    Article  CAS  Google Scholar 

  6. Tsai, V.W. et al. The anorectic actions of the TGFβ cytokine MIC-1/GDF15 require an intact brainstem area postrema and nucleus of the solitary tract. PLoS One 9, e100370 (2014).

    Article  Google Scholar 

  7. Bootcov, M.R. et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily. Proc. Natl. Acad. Sci. USA 94, 11514–11519 (1997).

    Article  CAS  Google Scholar 

  8. Unsicker, K., Spittau, B. & Krieglstein, K. The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1. Cytokine Growth Factor Rev. 24, 373–384 (2013).

    Article  CAS  Google Scholar 

  9. Mueller, T.D. & Nickel, J. Promiscuity and specificity in BMP receptor activation. FEBS Lett. 586, 1846–1859 (2012).

    Article  CAS  Google Scholar 

  10. Airaksinen, M.S. & Saarma, M. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3, 383–394 (2002).

    Article  CAS  Google Scholar 

  11. Airaksinen, M.S., Holm, L. & Hätinen, T. Evolution of the GDNF family ligands and receptors. Brain Behav. Evol. 68, 181–190 (2006).

    Article  Google Scholar 

  12. Cik, M. et al. Binding of GDNF and neurturin to human GDNF family receptor alpha 1 and 2. Influence of cRET and cooperative interactions. J. Biol. Chem. 275, 27505–27512 (2000).

    CAS  PubMed  Google Scholar 

  13. Parkash, V. et al. The structure of the glial cell line–derived neurotrophic factor–coreceptor complex: insights into RET signaling and heparin binding. J. Biol. Chem. 283, 35164–35172 (2008).

    Article  CAS  Google Scholar 

  14. Li, Z. et al. Identification, expression and functional characterization of the GRAL gene. J. Neurochem. 95, 361–376 (2005).

    Article  CAS  Google Scholar 

  15. Lutz, T.A., Mollet, A., Rushing, P.A., Riediger, T. & Scharrer, E. The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats. Int. J. Obes. Relat. Metab. Disord. 25, 1005–1011 (2001).

    Article  CAS  Google Scholar 

  16. Ahima, R.S. & Antwi, D.A. Brain regulation of appetite and satiety. Endocrinol. Metab. Clin. North Am. 37, 811–823 (2008).

    Article  CAS  Google Scholar 

  17. Day, H.E., McKnight, A.T., Poat, J.A. & Hughes, J. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology 33, 719–727 (1994).

    Article  CAS  Google Scholar 

  18. Riediger, T., Zuend, D., Becskei, C. & Lutz, T.A. The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut–brain axis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R114–R122 (2004).

    Article  CAS  Google Scholar 

  19. Dill, M.J., Shaw, J., Cramer, J. & Sindelar, D.K. 5-HT1A receptor antagonists reduce food intake and body weight by reducing total meals with no conditioned taste aversion. Pharmacol. Biochem. Behav. 112, 1–8 (2013).

    Article  CAS  Google Scholar 

  20. Wang, F. et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J. Mol. Diagn. 14, 22–29 (2012).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank J. Shou, X. Wu and D. Accili for helpful suggestions on the manuscript.

Author information

Authors and Affiliations

Authors

Contributions

P.J.E., M.D.G., T.C., R.S., R.E.G., B.B.Z., B.S. and X.W. designed and supervised the research. F.W., Y.D., Q.L., R.T.P., T.C., M.J.H., K.K.B., D.K.S., L.A.F., A.M., J.A.-F., G.C.B., J.X.T., X.L., X.M., P.J.M. and J.H.S. performed research. P.J.E., M.D.G., T.C., R.S. and X.W. analyzed data. P.J.E. and X.W. wrote the manuscript.

Corresponding author

Correspondence to Xinle Wu.

Ethics declarations

Competing interests

All authors declare competing financial interests as employees of Eli Lilly and Company.

Supplementary information

Supplementary Figures and Table

Supplementary Figures 1–6 and Supplementary Table 1. (PDF 620 kb)

Life Sciences Reporting Summary (PDF 130 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Emmerson, P., Wang, F., Du, Y. et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med 23, 1215–1219 (2017). https://doi.org/10.1038/nm.4393

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.4393

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing